151 related articles for article (PubMed ID: 27221393)
1. Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence.
Marcu LG
Crit Rev Oncol Hematol; 2016 Jul; 103():27-36. PubMed ID: 27221393
[TBL] [Abstract][Full Text] [Related]
2. Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.
Chung CH; Schwartz DL
Otolaryngol Clin North Am; 2012 Aug; 45(4):795-806. PubMed ID: 22793853
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
6. Recent data about the role of human papillomavirus (HPV) in oncogenesis of head and neck cancer.
Bădulescu F; Crişan A; Bădulescu A; Schenker M
Rom J Morphol Embryol; 2010; 51(3):437-40. PubMed ID: 20809017
[TBL] [Abstract][Full Text] [Related]
7. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV).
Young D; Xiao CC; Murphy B; Moore M; Fakhry C; Day TA
Oral Oncol; 2015 Aug; 51(8):727-30. PubMed ID: 26066977
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
9. Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy.
Eriksen JG; Lassen P
Recent Results Cancer Res; 2016; 198():143-61. PubMed ID: 27318685
[TBL] [Abstract][Full Text] [Related]
10. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.
Gooi Z; Chan JY; Fakhry C
Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of human papillomavirus in head and neck cancers.
Fakhry C; Gillison ML
J Clin Oncol; 2006 Jun; 24(17):2606-11. PubMed ID: 16763272
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
14. AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.
Guo T; Goldenberg D; Fakhry C
Head Neck; 2017 May; 39(5):833-839. PubMed ID: 28263449
[TBL] [Abstract][Full Text] [Related]
15. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
16. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
17. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
18. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
19. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
20. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
